America: Reproductive and Research Cloning
By Viginia Commonwealth University,
Viginia Commonwealth University
| 09. 14. 2005
How much do you favor or oppose...
| |
Strongly Favor |
Somewhat Favor |
Somewhat Oppose |
Strongly Oppose |
Don’t Know |
No Answer |
| allowing the cloning or genetically altering of humans |
3 |
12 |
18 |
63 |
2 |
2 |
| using human cloning technology IF it is used ONLY to help medical research develop new treatments for disease |
17 |
26 |
16 |
35 |
5 |
1 |
| using human cloning technology IF it is used to create human embryos that will provide stem cells for human therapeutic purposes |
11 |
23 |
18 |
41 |
6 |
2 |
How concerned are you that...
| |
Very concerned |
Somewhat concerned |
Not too concerned |
Not at all concerned |
Don’t Know |
No Answer |
| the use of human cloning technology to create stem cells for human therapeutic purposes will lead to a greater chance of human reproductive cloning |
33 |
35 |
18 |
8 |
4 |
2 |
Extensive crosstabs are available at pages 32-35 of the full survey report.
Related Articles
By Alistair Sponsel and Brian Sutton, Springer Nature | 10.05.2026
This essay, co-authored by a historian of science and an X-ray crystallographer, sheds new light on Rosalind Franklin’s Photograph 51. We refute the infamous claim that, unlike James Watson, Franklin failed to see the picture’s potential significance for interpreting the...
By Andrea Martani, BioNews | 10.05.2026
In July 2026, PET and ESHRE published a joint report containing the results of an international survey assessing public attitudes towards the use of embryos in the context of fertility treatment and research. Societal views on these matters are considered...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 09.29.2026
Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
